Neurodevelopmental Disorders Arising From Histone Methylation Malfunctions – Dr Shigeki Iwase, University Of Michigan
Original Article Reference
This SciPod is a summary of the paper:
https://doi.org/10.33548/SCIENTIA643
Share Episode
About this episode
Neurodevelopmental disorders range from those on the relatively common autism spectrum to much rarer disorders such as KDM5C-disorder and Weidemann-Steiner Syndrome. Exciting advancements in human genetics have shown that histones – the proteins our DNA wraps around – play a vital role in healthy brain development. Dr Shigeki Iwase from the University of Michigan studies how mutations in the enzymes that regulate histone structure and function can cause cognitive disorders. His work has led to important new discoveries, including how counterpart enzymes can be utilised for therapies.
This work is licensed under a Creative Commons Attribution 4.0 International License.
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
More episodes
Dr. Yassir Mahgoub | New Insights into Severe Depression Towards a Breakthrough in Treatment
Associate Professor Yassir Mahgoub and his team at Penn State University have uncovered an important link between melancholia – a severe form of depression that often doesn’t respond to treatment – and catatonia – a condition characterized by abnormal movements and associated with schizophrenia. The researchers analyzed case studies involving six patients who had been hospitalized for severe depression. All six patients experienced significant relief from their depressive symptoms by taking lorazepam – a drug typically used to treat catatonia. This discovery reveals a potential new avenue for treating severe, treatment-resistant depression.
Prof. Nelson Gekara | The Guardians of the Gut: A New Frontier in the Defence Against Viruses
Our gut contains a sleepless army, creating a hostile environment for pathogens, and helping to fortify our body’s immune defences. It may surprise you to learn that this army isn’t even human in nature, but is bacterial. The trillions of bacteria that naturally live in our gut, known as the gut microbiota, form an important component of our overall immunity against infectious disease. While bacteria can also cause disease, beneficial bacteria naturally colonise available spaces in our body, such as the gut, and play a key role in our immunity and physiology. Research conducted by Prof. Nelson Gekara of Stockholm University in Sweden and colleagues has revealed that these microscopic organisms play a crucial role in protecting us from viral infections, even in organs that are unconnected to the gut. Their study, published in the journal Immunity, uncovers a fascinating link between the gut microbiota and our body’s ability to fight viruses, offering new insights into immune function and the unintended consequences of antibiotic use.
Defending Authentic Leadership: A Response to Critical Claims
A recent paper from Professor William Gardner at Texas Tech University and Professor Kelly Davis McCauley at West Texas A&M University challenges a critique that characterized authentic leadership theory as “wrong” and “perilous.” Their analysis demonstrates how misrepresentations of the theory can undermine valuable leadership approaches, while highlighting the empirical support and practical benefits of leaders striving for authenticity in organizational settings.
Prof. Diana Jaalouk | Editing DNA and Degrading Proteins: The Tools to Achieve Precision Oncology
Cancer is a daunting healthcare challenge, and is still affecting millions worldwide, despite the enormous research resources that have been directed at finding effective treatments over the past decades. Many anti-cancer treatments remain poorly specific for the tumours they are intended to treat, and often suffer from modest efficacy and serious off-target effects. Part of the problem is the inherent variability between many tumours and their resulting unpredictable responses to standard chemotherapy. However, the latest advancements in precision oncology may be the start of a new paradigm, potentially providing targeted therapeutic payloads that can successfully address the specific and unique issues underlying a given patient’s cancer. Researchers such as Prof. Diana Jaalouk and her colleagues at the American University of Beirut in Lebanon are pioneering innovative tools that are changing the way we understand and treat this complex disease. Two remarkable recent technologies, CRISPR-Cas9 and PROteolysis TArgeting Chimeras (or PROTACs for short), are at the forefront of this precision revolution. While distinct in their approach, these tools share a common goal: targeting cancer with precision and minimizing harm to healthy cells. Together, they are set to reshape the therapeutic landscape.
Increase the impact of your research
• Good science communication helps people make informed decisions and motivates them to take appropriate and affirmative action.
• Good science communication encourages everyday people to be scientifically literate so that they can analyse the integrity and legitimacy of information.
• Good science communication encourages people into STEM-related fields of study and employment.
• Good public science communication fosters a community around research that includes both members of the public, policymakers and scientists.
• In a recent survey, 75% of people suggested they would prefer to listen to an interesting story than read it.

Step 1 Upload your science paper
Step 2 SciPod script written
Step 3 Voice audio recorded
Step 4 SciPod published